Garlic pills tested as shield against hospital superbugs
NCT ID NCT06833125
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether garlic tablets can prevent infections that patients often get while in the intensive care unit (ICU). Researchers will give garlic tablets to some ICU patients and compare them to others who do not receive the tablets. The goal is to see if garlic lowers the rate of serious infections like bloodstream or urinary tract infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- garlic tablets (allicin)
- What this could lead to
- If it works, this could offer a simple, low-cost way to reduce dangerous infections in intensive care patients.
- What could go wrong
- This is a small, early-phase trial with only 62 participants, so results may not apply broadly. Garlic may cause side effects like bleeding or stomach upset.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NOSOCOMIAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alexandria Main University Hospital
Alexandria, Alexandria Governorate, 21563, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.